| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
immunoglobulin heavy constant mu | 0.644 | 0.654 |
|
disease | 0.100 | None | 0 | 0 | ||||||||||||
|
N-acetylneuraminate synthase | 0.545 | 0.692 |
|
disease | 0.100 | None | 0 | 0 | ||||||||||||
|
RNA component of mitochondrial RNA processing endoribonuclease | 0.519 | 0.731 |
|
disease | 0.100 | None | 0 | 0 | ||||||||||||
|
sex determining region Y | 0.456 | 0.808 |
|
disease | 0.100 | None | 0 | 0 | ||||||||||||
|
Wolf-Hirschhorn syndrome chromosome region | 0.638 | 0.577 |
|
disease | 0.100 | None | 0 | 0 | ||||||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
dynein cytoplasmic 2 heavy chain 1 | 0.555 | 0.731 | 1.1E-44 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
NBAS subunit of NRZ tethering complex | 0.566 | 0.692 | 5.0E-43 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group I | 0.543 | 0.731 | 8.9E-37 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ciliogenesis and planar polarity effector 1 | 0.575 | 0.692 | 5.9E-36 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
RecQ like helicase 4 | 0.496 | 0.808 | 3.3E-35 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ryanodine receptor 1 | 0.489 | 0.808 | 1.6E-29 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
centrosome and spindle pole associated protein 1 | 0.544 | 0.769 | 3.3E-29 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
KIAA0753 | 0.631 | 0.577 | 1.6E-28 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
solute carrier family 3 member 1 | 0.593 | 0.731 | 7.2E-27 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
Abelson helper integration site 1 | 0.513 | 0.846 | 1.1E-25 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
intraflagellar transport 122 | 0.560 | 0.846 | 2.4E-24 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group L | 0.551 | 0.731 | 5.9E-23 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
phenylalanine hydroxylase | 0.516 | 0.769 | 6.4E-23 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
WD repeat domain 35 | 0.525 | 0.692 | 1.0E-22 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
SLX4 structure-specific endonuclease subunit | 0.565 | 0.731 | 1.6E-22 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
kinesin family member 7 | 0.528 | 0.731 | 2.3E-22 |
|
disease | 0.100 | None | 0 | 0 |